Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients - Markers for risk assessment?

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 6, 2011, Pages 1399-1403

  Cobanoglu, Ufuk ^a   Demir, Halit ^a   Cebi, Aysegul ^b   Sayir, Fuat ^a   Alp, Hamit Hakan ^c   Akan, Zafer ^a   Gur, Tugba ^a   Bakan, Ebubekir ^c  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b GIRESUN UNIVERSITY   (Turkey)

^c ATATURK UNIVERSITY   (Turkey)

Author keywords

8 oHdG; Coenzyme Q10; DNA damage; HPLC; Lung cancer; MDA

Indexed keywords

EID: 84858046465     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ames BN (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221,1256-64.
2. Artuch R, Vilaseca MA, Moreno J, et al (1999). Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutr, 70, 892-5.
3. Bhagavan HN, Chopra RK, Craft NE, et al (2007). Assessment of coenzyme Q10 absorption using an in vitro digestion-Caco-2 cell model. Int J Pharm, 333,112-7.
4. Bonakdar RA, Guarneri E (2005). Coenzyme Q10. Am Fam Physician, 72,1065-70.
5. Crane FL (2001). Biochemical functions of coenzyme Q10. J Am Coll Nutr, 20, 591-8.
6. Cross CE, Halliwell B, Borish ET, et al (1987). Oxygen radicals and human disease. Ann Intern Med, 107, 526-45.
7. Dandona P, Thusu K, Cook S, et al (1996). Oxidative damage to DNA in diabetes mellitus. Lancet, 347, 444-5.
8. Demir C, Demir H, Esen R, et al (2010). Erythrocyte catalase and carbonic anhydrase activities in acute leukemias. Asian Pac J Cancer Prev, 11, 247-50.
9. Dizdaroglu M (1994). Chemical determination of oxidative DNA damage by gas chromatography-mass spectrometry. Methods Enzymol, 234, 3-16.
10. Dizdaroglu M, Jaruga P, Rodriguez H (2001). Measurement of 8-hydroxy-2′ deoxyguanosine in DNA by high-performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry. Nucleic Acids Res, 29, E12.
11. Donald JA, Salmon JA, Adams LJ, et al (1997). Parental sex effects in bipolar affective disorder pedigrees. Genet Epidemiol, 14, 611-6.
12. Dormandy TL (1983). An approach to free radicals. Lancet, 2,1010-4.
13. Duncan MW (2009). Place for biochemical markers in early-stage lung cancer detection? J Clin Oncol, 27, 2749-50.
14. Erhola M, Toyokuni S, Okada K, et al (1997). Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett, 409, 287-91.
15. Esme H, Cemek M, Sezer M, et al (2008). High levels of oxidative stress in patients with advanced lung cancer. Respirology, 13,112-6.
16. Folkers K, Brown R, Judy WV, et al (1993). Survival of cancer patients on therapy with co-enzyme Q10. Biochem Biophys Res Commun, 192, 241-245.
17. Fraga CG, Shigenaga MK, Park JW, et al (1990). Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA, 87, 4533-7.
18. Gutteridge JM (1995). Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem, 41,1819-28.
19. Guyton KZ, Kensler TW (1993). Oxidative mechanisms in carcinogenesis. Br Med Bull, 49, 523-44.
20. Halliwell B (1997). Antioxidants and human disease: a general introduction. Nutr Rev, 55(1 Pt 2):S44-9; discussion S9-52.
21. Halliwell B (1999). Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev, 57, 104-13.
22. Hirano T, Yamaguchi R, Asami S, et al (1996). 8-hydroxyguanine levels in nuclear DNA and its repair activity in rat organs associated with age. J Gerontol A Biol Sci Med Sci, 51, 303-7.
23. Honda M, Yamada Y, Tomonaga M, et al (2000). Correlation of urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res, 24, 461-8.
24. Kasai H, Nishimura S (1984). Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res,12, 2137-45.
25. Khoschsorur GA, Winklhofer-Roob B. M, Rab PH, et al (2000). Evaluation of a Sensitive HPLC Method for the Determination of Malondialdehyde and Application of the Method to Different Biological Materials. Chromatographi A, 52, 181-184.
26. Lockwood K, Moesgaard S, Yamamoto T, et al (1995). Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun, 212, 172-7.
27. Loft S, Poulsen HE (1999). Markers of oxidative damage to DNA: Antioxidants and moleculer damage. Methods in Enzymology, 300, 167-84.
28. Menke T, Niklowitz P, Adam S, et al (2000). Simultaneous detection of ubiquinol-10, ubiquinone-10, and tocopherols in human plasma microsamples and macrosamples as a marker of oxidative damage in neonates and infants. Anal Biochem, 282, 209-17.
29. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
30. Moriya K, Nakagawa K, Santa T, et al (2001). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res, 61, 4365-70.
31. Murray CJ, Lopez AD (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet,349,1498-504.
32. Overvad K, Diamant B, Holm L, et al (1999). Coenzyme Q10 in health and disease. Eur J Clin Nutr,53, 764-70.
33. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
34. Quiles JL, Ochoa JJ, Huertas JR, et al (2004). Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet. Exp Gerontol, 39, 189-94.
35. Radzikowska E, Roszkowski K, Glaz P (2001). Lung cancer in patients under 50 years old. Lung Cancer, 33, 203-11.
36. Ruiz-Jimenez J, Priego-Capote F, Mata-Granados JM, et al (2007). Determination of the ubiquinol-10 and ubiquinone-10 (coenzyme Q10) in human serum by liquid chromatography tandem mass spectrometry to evaluate the oxidative stress. J Chromatogr A, 1175, 242-8.
37. Senturker S, Dizdaroglu M (1999). The effect of experimental conditions on the levels of oxidatively modified bases in DNA as measured by gas chromatography-mass spectrometry: how many modified bases are involved? Prepurification or not? Free Radic Biol Med, 27, 370-80.
38. Shigenaga MK, Ames BN (1991). Assays for 8-hydroxy-2'-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med,10, 211-6.
39. Shigenaga MK, Gimeno CJ, Ames BN (1989). Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA, 86, 9697-701.
40. Spiro SG, Porter JC (2002). Lung cancer, where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med,166, 1166-96.
41. Turunen M, Olsson J, Dallner G (2004). Metabolism and function of coenzyme Q. Biochim Biophys Acta,1660, 171-99.
42. Wiseman H, Halliwell B (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J, 313, 17-29.
43. Yee J, Sadar MD, Sin DD, et al (2009). Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol, 27, 2787-92.